EYEVENSYS
Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasive procedures. Eyevensysโ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability. They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
EYEVENSYS
Social Links:
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2008-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.eyevensys.com
Total Employee:
11+
Status:
Active
Contact:
+33 (0)1 84 79 10 60
Email Addresses:
[email protected]
Total Funding:
52.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Current Advisors List
Current Employees Featured
Founder
Investors List
Korea Investment Partners
Korea Investment Partners investment in Series B - Eyevensys
Karista
Karista investment in Series B - Eyevensys
Quark Venture
Quark Venture investment in Series B - Eyevensys
Global health sciences venture fund
Global health sciences venture fund investment in Series B - Eyevensys
Bpifrance
Bpifrance investment in Series B - Eyevensys
Inserm Transfert Initiative
Inserm Transfert Initiative investment in Series B - Eyevensys
Pureos Bioventures
Pureos Bioventures investment in Series B - Eyevensys
Pontifax
Pontifax investment in Series B - Eyevensys
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - Eyevensys
Pontifax
Pontifax investment in Series A - Eyevensys
Key Employee Changes
Date | New article |
---|---|
2020-03-10 | Eyevensys Announces Executive Leadership Team Expansion |
Official Site Inspections
http://www.eyevensys.com Semrush global rank: 5.79 M Semrush visits lastest month: 1.44 K
- Host name: redirect.ovh.net
- IP address: 213.186.33.5
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris